Skip to main content
NCBI home page
British Heart Journal logoLink to British Heart Journal
. 1983 Apr;49(4):305–308. doi: 10.1136/hrt.49.4.305

Converting enzyme inhibitors in hypertension and heart failure.

H J Dargie, S G Ball, A B Atkinson, J I Robertson
PMCID: PMC481304  PMID: 6299314

Full text

PDF
305

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ader R., Chatterjee K., Ports T., Brundage B., Hiramatsu B., Parmley W. Immediate and sustained hemodynamic and clinical improvement in chronic heart failure by an oral angiotensin-converting enzyme inhibitor. Circulation. 1980 May;61(5):931–937. doi: 10.1161/01.cir.61.5.931. [DOI] [PubMed] [Google Scholar]
  2. Antonaccio M. J., Kerwin L. Evidence for prejunctional inhibition of norepinephrine release by captopril in spontaneously hypertensive rats. Eur J Pharmacol. 1980 Nov 21;68(2):209–212. doi: 10.1016/0014-2999(80)90325-8. [DOI] [PubMed] [Google Scholar]
  3. Atkinson A. B., Brown J. J., Lever A. F., Robertson J. I. Combined treatment of severe intractable hypertension with captopril and diuretic. Lancet. 1980 Jul 19;2(8186):105–108. doi: 10.1016/s0140-6736(80)90001-x. [DOI] [PubMed] [Google Scholar]
  4. Atkinson A. B., Cumming A. M., Brown J. J., Fraser R., Leckie B., Lever A. F., Morton J. J., Robertson J. I. Captopril treatment: inter-dose variations in renin, angiotensins I and II, aldosterone and blood pressure. Br J Clin Pharmacol. 1982 Jun;13(6):855–858. doi: 10.1111/j.1365-2125.1982.tb01878.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Atkinson A. B., Robertson J. I. Captopril in the treatment of clinical hypertension and cardiac failure. Lancet. 1979 Oct 20;2(8147):836–839. doi: 10.1016/s0140-6736(79)92186-x. [DOI] [PubMed] [Google Scholar]
  6. Awan N. A., Evenson M. K., Needham K. E., Win A., Mason D. T. Efficacy of oral angiotensin-converting enzyme inhibition with captopril therapy in severe chronic normotensive congestive heart failure. Am Heart J. 1981 Jan;101(1):22–31. doi: 10.1016/0002-8703(81)90379-3. [DOI] [PubMed] [Google Scholar]
  7. Brown J. J., Casals-Stenzel J., Cumming A. M., Davies D. L., Fraser R., Lever A. F., Morton J. J., Semple P. F., Tree M., Robertson J. I. Angiotensin II, aldosterone and arterial pressure: a quantitative approach. Arthur C. Corcoran Memorial Lecture. Hypertension. 1979 May-Jun;1(3):159–179. doi: 10.1161/01.hyp.1.3.159. [DOI] [PubMed] [Google Scholar]
  8. Brown J. J., Davies D. L., Johnson V. W., Lever A. F., Robertson J. I. Renin relationships in congestive cardiac failure, treated and untreated. Am Heart J. 1970 Sep;80(3):329–342. doi: 10.1016/0002-8703(70)90098-0. [DOI] [PubMed] [Google Scholar]
  9. Case D. B., Atlas S. A., Laragh J. H., Sealey J. E., Sullivan P. A., McKinstry D. N. Clinical experience with blockade of the renin-angiotensin-aldosterone system by an oral converting-enzyme inhibitor (SQ 14,225, captopril) in hypertensive patients. Prog Cardiovasc Dis. 1978 Nov-Dec;21(3):195–206. doi: 10.1016/0033-0620(78)90025-7. [DOI] [PubMed] [Google Scholar]
  10. Cohn J. N. Relationship of plasma volume changes to resistance and capacitance vessel effects of sympathomimetic amines and angiotensin in man. Clin Sci. 1966 Apr;30(2):267–278. [PubMed] [Google Scholar]
  11. Conway J., Hatton R., Keddie J., Dawes P. The role of angiotensin in the control of blood pressure during sodium depletion. Hypertension. 1979 Jul-Aug;1(4):402–409. doi: 10.1161/01.hyp.1.4.402. [DOI] [PubMed] [Google Scholar]
  12. Heel R. C., Brogden R. N., Speight T. M., Avery G. S. Captopril: a preliminary review of its pharmacological properties and therapeutic efficacy. Drugs. 1980 Dec;20(6):409–452. doi: 10.2165/00003495-198020060-00001. [DOI] [PubMed] [Google Scholar]
  13. Hodsman G. P., Brown J. J., Davies D. L., Fraser R., Lever A. F., Morton J. J., Murray G. D., Robertson J. I. Converting-enzyme inhibitor enalapril (MK421) in treatment of hypertension with renal artery stenosis. Br Med J (Clin Res Ed) 1982 Dec 11;285(6356):1697–1699. doi: 10.1136/bmj.285.6356.1697. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Joy M. D. The intramedullary connections of the area postrema involved in the central cardiovascular response to angiotensin II. Clin Sci. 1971 Aug;41(2):89–100. doi: 10.1042/cs0410089. [DOI] [PubMed] [Google Scholar]
  15. Levine T. B., Franciosa J. A., Cohn J. N. Acute and long-term response to an oral converting-enzyme inhibitor, captopril, in congestive heart failure. Circulation. 1980 Jul;62(1):35–41. doi: 10.1161/01.cir.62.1.35. [DOI] [PubMed] [Google Scholar]
  16. Linnell J. C., Collings L., Down M. C., England J. M. Distribution of endogenous cobalamin between the transcobalamins in various mammals. Clin Sci (Lond) 1979 Aug;57(2):139–144. doi: 10.1042/cs0570139. [DOI] [PubMed] [Google Scholar]
  17. Morton J. J., Tree M., Casals-Stenzel J. Effect of infused captopril on blood pressure and the renin-angiotensin-aldosterone system in normal dogs subjected to varying sodium balance. Am J Cardiol. 1982 Apr 21;49(6):1395–1400. doi: 10.1016/0002-9149(82)90349-6. [DOI] [PubMed] [Google Scholar]
  18. Ondetti M. A., Rubin B., Cushman D. W. Design of specific inhibitors of angiotensin-converting enzyme: new class of orally active antihypertensive agents. Science. 1977 Apr 22;196(4288):441–444. doi: 10.1126/science.191908. [DOI] [PubMed] [Google Scholar]
  19. Patchett A. A., Harris E., Tristram E. W., Wyvratt M. J., Wu M. T., Taub D., Peterson E. R., Ikeler T. J., ten Broeke J., Payne L. G. A new class of angiotensin-converting enzyme inhibitors. Nature. 1980 Nov 20;288(5788):280–283. doi: 10.1038/288280a0. [DOI] [PubMed] [Google Scholar]
  20. Pierpont G. L., Francis G. S., Cohn J. N. Effect of captopril on renal function in patients with congestive heart failure. Br Heart J. 1981 Nov;46(5):522–527. doi: 10.1136/hrt.46.5.522. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Sharpe D. N., Douglas J. E., Coxon R. J., Long B. Low-dose captopril in chronic heart failure: acute haemodynamic effects and long-term treatment. Lancet. 1980 Nov 29;2(8205):1154–1157. doi: 10.1016/s0140-6736(80)92593-3. [DOI] [PubMed] [Google Scholar]
  22. Swartz S. L., Williams G. H., Hollenberg N. K., Moore T. J., Dluhy R. G. Converting enzyme inhibition in essential hypertension: the hypotensive response does not reflect only reduced angiotensin II formation. Hypertension. 1979 Mar-Apr;1(2):106–111. doi: 10.1161/01.hyp.1.2.106. [DOI] [PubMed] [Google Scholar]
  23. Turini G. A., Brunner H. R., Gribic M., Waeber B., Gavras H. Improvement of chronic congestive heart-failure by oral captopril. Lancet. 1979 Jun 9;1(8128):1213–1215. doi: 10.1016/s0140-6736(79)91897-x. [DOI] [PubMed] [Google Scholar]
  24. White N. J., Rajagopalan B., Yahaya H., Ledingham J. G. Captopril and frusemide in severe drug-resistant hypertension. Lancet. 1980 Jul 19;2(8186):108–110. doi: 10.1016/s0140-6736(80)90002-1. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES